EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

Effect of Peritumoral Infiltration of Local Anesthetic Before Surgery on Survival in Early Breast Cancer

Rajendra A Badwe iD, Vani Parmar iD, Nita Nair iD, Shalaka Joshi iD, Rohini Hawaldar iD, Suraj Pawar, Geeta Kadayaprath, Bibhuti B Borthakur iD, Subramanyeshwar Rao Thammineedi iD, Shashank Pandya, Satheesan Balasubramanian iD, Priyadarshan V Chitale iD und 8 weitere

Journal of Clinical Oncology · 20.06.2023 · 41 (18) · 3318-3328

DOI: 10.1200/jco.22.01966 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Oncology, erschienen am 20.06.2023. Verfasst von Rajendra A Badwe und 19 weiteren Autor:innen. Beteiligte Einrichtung: Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 113-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Preventing metastases by using perioperative interventions has not been adequately explored. Local anesthesia blocks voltage-gated sodium channels and thereby prevents activation of prometastatic pathways. We conducted an open-label, multicenter randomized trial to test the impact of presurgical, peritumoral infiltration of local anesthesia on disease-free survival (DFS). METHODS Women with early breast cancer planned for upfront surgery without prior neoadjuvant treatment were randomly assigned to receive peritumoral injection of 0.5% lidocaine, 7-10 minutes before surgery (local anesthetics [LA] arm) or surgery without lidocaine (no LA arm). Random assignment was stratified by menopausal status, tumor size, and center. Participants received standard postoperative adjuvant treatment. Primary and secondary end points were DFS and overall survival (OS), respectively. RESULTS Excluding eligibility violations, 1,583 of 1,600 randomly assigned patients were included in this analysis (LA, 796; no LA, 804). At a median follow-up of 68 months, there were 255 DFS events (LA, 109; no LA, 146) and 189 deaths (LA, 79; no LA, 110). In LA and no LA arms, 5-year DFS rates were 86.6% and 82.6% (hazard ratio [HR], 0.74; 95% CI, 0.58 to 0.95; P = .017) and 5-year OS rates were 90.1% and 86.4%, respectively (HR, 0.71; 95% CI, 0.53 to 0.94; P = .019). The impact of LA was similar in subgroups defined by menopausal status, tumor size, nodal metastases, and hormone receptor and human epidermal growth factor receptor 2 status. Using competing risk analyses, in LA and no LA arms, 5-year cumulative incidence rates of locoregional recurrence were 3.4% and 4.5% (HR, 0.68; 95% CI, 0.41 to 1.11), and distant recurrence rates were 8.5% and 11.6%, respectively (HR, 0.73; 95% CI, 0.53 to 0.99). There were no adverse events because of lidocaine injection. CONCLUSION Peritumoral injection of lidocaine before breast cancer surgery significantly increases DFS and OS. Altering events at the time of surgery can prevent metastases in early breast cancer (CTRI/2014/11/005228). [Media: see text]

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsFemaleHumansAnesthetics, LocalAnesthesia, LocalNeoplasm Recurrence, LocalDisease-Free SurvivalLidocaineChemotherapy, Adjuvant

Substanzen

Anesthetics, LocalLidocaine

Autor:innen und Institutionen

  • Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Kolhapur Cancer Centre, Kolhapur, India.
  • Max Superspeciality Hospital, Patparganj, New Delhi, India.
  • B. Borooah Cancer Institute, Guwahati, India.
  • Basavatarakam Indo-American Cancer Hospital and Research Centre, Hyderabad, India.
  • Gujarat Cancer & Research Institute, Ahmedabad, India.

ORCID-Profile: Rajendra A Badwe, Vani Parmar, Nita Nair, Shalaka Joshi, Rohini Hawaldar, Bibhuti B Borthakur, Subramanyeshwar Rao Thammineedi, Satheesan Balasubramanian, Priyadarshan V Chitale, Rakesh Neve, Anurag Srivastava, Ashwini Dewade, Sudeep Gupta

Zitieren

APA

Badwe, R. A., Parmar, V., Nair, N., Joshi, S., Hawaldar, R., Pawar, S., Kadayaprath, G., Borthakur, B. B., Rao Thammineedi, S., Pandya, S., Balasubramanian, S., Chitale, P. V., Neve, R., Harris, C., Srivastava, A., Siddique, S., Vanmali, V. J., Dewade, A., Gaikwad, V., & Gupta, S. (2023). Effect of Peritumoral Infiltration of Local Anesthetic Before Surgery on Survival in Early Breast Cancer. Journal of Clinical Oncology, 41(18), 3318-3328. https://doi.org/10.1200/jco.22.01966

Vancouver

Badwe RA, Parmar V, Nair N, Joshi S, Hawaldar R, Pawar S, et al. Effect of Peritumoral Infiltration of Local Anesthetic Before Surgery on Survival in Early Breast Cancer. Journal of Clinical Oncology. 2023;41(18):3318-3328. doi:10.1200/jco.22.01966

BibTeX
@article{Badwe2023,
  author = {Badwe, Rajendra A and Parmar, Vani and Nair, Nita and Joshi, Shalaka and Hawaldar, Rohini and Pawar, Suraj and Kadayaprath, Geeta and Borthakur, Bibhuti B and Rao Thammineedi, Subramanyeshwar and Pandya, Shashank and Balasubramanian, Satheesan and Chitale, Priyadarshan V and Neve, Rakesh and Harris, Caleb and Srivastava, Anurag and Siddique, Shabina and Vanmali, Vaibhav J and Dewade, Ashwini and Gaikwad, Varsha and Gupta, Sudeep},
  title = {Effect of Peritumoral Infiltration of Local Anesthetic Before Surgery on Survival in Early Breast Cancer},
  journal = {Journal of Clinical Oncology},
  year = {2023},
  volume = {41},
  number = {18},
  pages = {3318--3328},
  doi = {10.1200/jco.22.01966}
}
Kostenlos starten →